Annual Total Long Term Liabilities
$90.10 K
-$115.40 K-56.16%
December 31, 2023
Summary
- As of February 7, 2025, IKT annual total long term liabilities is $90.10 thousand, with the most recent change of -$115.40 thousand (-56.16%) on December 31, 2023.
- During the last 3 years, IKT annual total long term liabilities has fallen by -$186.40 thousand (-67.41%).
- IKT annual total long term liabilities is now -67.41% below its all-time high of $276.50 thousand, reached on December 31, 2020.
Performance
IKT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
-$25.60 K-100.00%
September 30, 2024
Summary
- As of February 7, 2025, IKT quarterly total long term liabilities is $0.00, with the most recent change of -$25.60 thousand (-100.00%) on September 30, 2024.
- Over the past year, IKT quarterly long term liabilities has dropped by -$25.60 thousand (-100.00%).
- IKT quarterly long term liabilities is now -100.00% below its all-time high of $675.00 thousand, reached on September 30, 2020.
Performance
IKT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
IKT Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.2% | -100.0% |
| 3 y3 years | -67.4% | -100.0% |
| 5 y5 years | +100.0% | -100.0% |
IKT Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -56.2% | -100.0% | -100.0% | at low |
| 5 y | 5-year | -67.4% | -100.0% | -100.0% | at low |
| alltime | all time | -67.4% | -100.0% | -100.0% | at low |
Inhibikase Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) |
| Jun 2024 | - | $25.60 K(-56.1%) |
| Mar 2024 | - | $58.30 K(-35.3%) |
| Dec 2023 | $90.10 K(-56.2%) | $90.10 K(-25.5%) |
| Sep 2023 | - | $121.00 K(-19.3%) |
| Jun 2023 | - | $150.00 K(-15.8%) |
| Mar 2023 | - | $178.10 K(-13.3%) |
| Dec 2022 | $205.50 K | $205.50 K(-11.4%) |
| Sep 2022 | - | $232.00 K(>+9900.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $0.00(0.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(-100.0%) |
| Jun 2021 | - | $248.90 K(0.0%) |
| Mar 2021 | - | $248.90 K(-10.0%) |
| Dec 2020 | $276.50 K(+0.4%) | $276.50 K(-59.0%) |
| Sep 2020 | - | $675.00 K(+7.7%) |
| Jun 2020 | - | $626.80 K(+100.3%) |
| Mar 2020 | - | $312.90 K(+13.6%) |
| Dec 2019 | $275.40 K(>+9900.0%) | $275.40 K |
| Dec 2018 | $0.00 | - |
FAQ
- What is Inhibikase Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics annual total long term liabilities year-on-year change?
- What is Inhibikase Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics quarterly long term liabilities year-on-year change?
What is Inhibikase Therapeutics annual total long term liabilities?
The current annual total long term liabilities of IKT is $90.10 K
What is the all time high annual total long term liabilities for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high annual total long term liabilities is $276.50 K
What is Inhibikase Therapeutics annual total long term liabilities year-on-year change?
Over the past year, IKT annual total long term liabilities has changed by -$115.40 K (-56.16%)
What is Inhibikase Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of IKT is $0.00
What is the all time high quarterly long term liabilities for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high quarterly total long term liabilities is $675.00 K
What is Inhibikase Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, IKT quarterly total long term liabilities has changed by -$25.60 K (-100.00%)